Development and manufacturing of innovative perinatal products for research and clinical trials
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
9
NCT05947617
Safety, Efficacy, and Dosing of VIX001 in Patients With Neurological Symptoms of Post Acute COVID-19 Syndrome (PACS).
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 1, 2023
Completion: Sep 1, 2025
Loading map...